Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2014

Open Access 01-02-2014 | Research article

Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation

Authors: Takeo Isozaki, Jeffrey H Ruth, Mohammad A Amin, Phillip L Campbell, Pei-Suen Tsou, Christine M Ha, G Kenneth Haines III, Gautam Edhayan, Alisa E Koch

Published in: Arthritis Research & Therapy | Issue 1/2014

Login to get access

Abstract

Introduction

We previously reported that sialyl Lewisy, synthesized by fucosyltransferases, is involved in angiogenesis. Fucosyltransferase 1 (fut1) is an α(1,2)-fucosyltransferase responsible for synthesis of the H blood group and Lewisy antigens. However, the angiogenic involvement of fut 1 in the pathogenesis of rheumatoid arthritis synovial tissue (RA ST) has not been clearly defined.

Methods

Assay of α(1,2)-linked fucosylated proteins in RA was performed by enzyme-linked lectin assay. Fut1 expression was determined in RA ST samples by immunohistological staining. We performed angiogenic Matrigel assays using a co-culture system of human dermal microvascular endothelial cells (HMVECs) and fut1 small interfering RNA (siRNA) transfected RA synovial fibroblasts. To determine if fut1 played a role in leukocyte retention and cell proliferation in the RA synovium, myeloid THP-1 cell adhesion assays and fut1 siRNA transfected RA synovial fibroblast proliferation assays were performed.

Results

Total α(1,2)-linked fucosylated proteins in RA ST were significantly higher compared to normal (NL) ST. Fut1 expression on RA ST lining cells positively correlated with ST inflammation. HMVECs from a co-culture system with fut1 siRNA transfected RA synovial fibroblasts exhibited decreased endothelial cell tube formation compared to control siRNA transfected RA synovial fibroblasts. Fut1 siRNA also inhibited myeloid THP-1 adhesion to RA synovial fibroblasts and RA synovial fibroblast proliferation.

Conclusions

These data show that α(1,2)-linked fucosylated proteins are upregulated in RA ST compared to NL ST. We also show that fut1 in RA synovial fibroblasts is important in angiogenesis, leukocyte-synovial fibroblast adhesion, and synovial fibroblast proliferation, all key processes in the pathogenesis of RA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, Strieter RM: Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol. 1991, 147: 2187-2195.PubMed Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, Strieter RM: Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol. 1991, 147: 2187-2195.PubMed
2.
3.
go back to reference Kunkel SL, Lukacs N, Kasama T, Strieter RM: The role of chemokines in inflammatory joint disease. J Leukoc Biol. 1996, 59: 6-12.PubMed Kunkel SL, Lukacs N, Kasama T, Strieter RM: The role of chemokines in inflammatory joint disease. J Leukoc Biol. 1996, 59: 6-12.PubMed
4.
go back to reference Choy EH, Panayi GS: Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001, 344: 907-916. 10.1056/NEJM200103223441207.CrossRefPubMed Choy EH, Panayi GS: Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001, 344: 907-916. 10.1056/NEJM200103223441207.CrossRefPubMed
5.
go back to reference Koch AE: Chemokines and their receptors in rheumatoid arthritis: future targets?. Arthritis Rheum. 2005, 52: 710-721. 10.1002/art.20932.CrossRefPubMed Koch AE: Chemokines and their receptors in rheumatoid arthritis: future targets?. Arthritis Rheum. 2005, 52: 710-721. 10.1002/art.20932.CrossRefPubMed
6.
go back to reference Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK: Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum. 2003, 48: 35-45. 10.1002/art.10697.CrossRefPubMed Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK: Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum. 2003, 48: 35-45. 10.1002/art.10697.CrossRefPubMed
7.
go back to reference Nishimoto N: Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol. 2006, 18: 277-281. 10.1097/01.bor.0000218949.19860.d1.CrossRefPubMed Nishimoto N: Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol. 2006, 18: 277-281. 10.1097/01.bor.0000218949.19860.d1.CrossRefPubMed
8.
go back to reference Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM: Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest. 1994, 93: 921-928. 10.1172/JCI117097.CrossRefPubMedPubMedCentral Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM: Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest. 1994, 93: 921-928. 10.1172/JCI117097.CrossRefPubMedPubMedCentral
9.
go back to reference Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992, 258: 1798-1801. 10.1126/science.1281554.CrossRefPubMed Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992, 258: 1798-1801. 10.1126/science.1281554.CrossRefPubMed
10.
go back to reference Carmeliet P: Angiogenesis in life, disease and medicine. Nature. 2005, 438: 932-936. 10.1038/nature04478.CrossRefPubMed Carmeliet P: Angiogenesis in life, disease and medicine. Nature. 2005, 438: 932-936. 10.1038/nature04478.CrossRefPubMed
11.
go back to reference Johnson BA, Haines GK, Harlow LA, Koch AE: Adhesion molecule expression in human synovial tissue. Arthritis Rheum. 1993, 36: 137-146. 10.1002/art.1780360203.CrossRefPubMed Johnson BA, Haines GK, Harlow LA, Koch AE: Adhesion molecule expression in human synovial tissue. Arthritis Rheum. 1993, 36: 137-146. 10.1002/art.1780360203.CrossRefPubMed
12.
13.
go back to reference Dunphy WG, Brands R, Rothman JE: Attachment of terminal N-acetylglucosamine to asparagine-linked oligosaccharides occurs in central cisternae of the Golgi stack. Cell. 1985, 40: 463-472. 10.1016/0092-8674(85)90161-8.CrossRefPubMed Dunphy WG, Brands R, Rothman JE: Attachment of terminal N-acetylglucosamine to asparagine-linked oligosaccharides occurs in central cisternae of the Golgi stack. Cell. 1985, 40: 463-472. 10.1016/0092-8674(85)90161-8.CrossRefPubMed
14.
go back to reference Aplin JD, Jones CJ: Fucose, placental evolution and the glycocode. Glycobiology. 2012, 22: 470-478. 10.1093/glycob/cwr156.CrossRefPubMed Aplin JD, Jones CJ: Fucose, placental evolution and the glycocode. Glycobiology. 2012, 22: 470-478. 10.1093/glycob/cwr156.CrossRefPubMed
15.
go back to reference Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB: Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem. 1995, 270: 4640-4649. 10.1074/jbc.270.9.4640.CrossRefPubMed Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB: Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem. 1995, 270: 4640-4649. 10.1074/jbc.270.9.4640.CrossRefPubMed
16.
go back to reference Larsen RD, Ernst LK, Nair RP, Lowe JB: Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA. 1990, 87: 6674-6678. 10.1073/pnas.87.17.6674.CrossRefPubMedPubMedCentral Larsen RD, Ernst LK, Nair RP, Lowe JB: Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA. 1990, 87: 6674-6678. 10.1073/pnas.87.17.6674.CrossRefPubMedPubMedCentral
17.
go back to reference Sun J, Thurin J, Cooper HS, Wang P, Mackiewicz M, Steplewski Z, Blaszczyk-Thurin M: Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc Natl Acad Sci USA. 1995, 92: 5724-5728. 10.1073/pnas.92.12.5724.CrossRefPubMedPubMedCentral Sun J, Thurin J, Cooper HS, Wang P, Mackiewicz M, Steplewski Z, Blaszczyk-Thurin M: Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc Natl Acad Sci USA. 1995, 92: 5724-5728. 10.1073/pnas.92.12.5724.CrossRefPubMedPubMedCentral
18.
go back to reference Mas E, Pasqualini E, Caillol N, El Battari A, Crotte C, Lombardo D, Sadoulet MO: Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines. Glycobiology. 1998, 8: 605-613. 10.1093/glycob/8.6.605.CrossRefPubMed Mas E, Pasqualini E, Caillol N, El Battari A, Crotte C, Lombardo D, Sadoulet MO: Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines. Glycobiology. 1998, 8: 605-613. 10.1093/glycob/8.6.605.CrossRefPubMed
19.
go back to reference De Benedetti F, Pignatti P, Biffi M, Bono E, Wahid S, Ingegnoli F, Chang SY, Alexander H, Massa M, Pistorio A, Martini A, Pitzalis C, Sinigaglia F, Rogge L: Increased expression of alpha(1,3)-fucosyltransferase-VII and P-selectin binding of synovial fluid T cells in juvenile idiopathic arthritis. J Rheumatol. 2003, 30: 1611-1615.PubMed De Benedetti F, Pignatti P, Biffi M, Bono E, Wahid S, Ingegnoli F, Chang SY, Alexander H, Massa M, Pistorio A, Martini A, Pitzalis C, Sinigaglia F, Rogge L: Increased expression of alpha(1,3)-fucosyltransferase-VII and P-selectin binding of synovial fluid T cells in juvenile idiopathic arthritis. J Rheumatol. 2003, 30: 1611-1615.PubMed
20.
go back to reference Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature. 1995, 376: 517-519. 10.1038/376517a0.CrossRefPubMed Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature. 1995, 376: 517-519. 10.1038/376517a0.CrossRefPubMed
21.
go back to reference Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, Woods JM, Campbell PL, Volin MV, Backer AE, Koch AE: Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol. 2000, 164: 4868-4877.CrossRefPubMed Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, Woods JM, Campbell PL, Volin MV, Backer AE, Koch AE: Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol. 2000, 164: 4868-4877.CrossRefPubMed
22.
go back to reference Zhu K, Amin MA, Kim MJ, Katschke KJ, Park CC, Koch AE: A novel function for a glucose analog of blood group H antigen as a mediator of leukocyte-endothelial adhesion via intracellular adhesion molecule 1. J Biol Chem. 2003, 278: 21869-21877. 10.1074/jbc.M213052200.CrossRefPubMed Zhu K, Amin MA, Kim MJ, Katschke KJ, Park CC, Koch AE: A novel function for a glucose analog of blood group H antigen as a mediator of leukocyte-endothelial adhesion via intracellular adhesion molecule 1. J Biol Chem. 2003, 278: 21869-21877. 10.1074/jbc.M213052200.CrossRefPubMed
23.
go back to reference Koch AE, Volin MV, Woods JM, Kunkel SL, Connors MA, Harlow LA, Woodruff DC, Burdick MD, Strieter RM: Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum. 2001, 44: 31-40. 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4.CrossRefPubMed Koch AE, Volin MV, Woods JM, Kunkel SL, Connors MA, Harlow LA, Woodruff DC, Burdick MD, Strieter RM: Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum. 2001, 44: 31-40. 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4.CrossRefPubMed
24.
go back to reference Ahmed S, Pakozdi A, Koch AE: Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2006, 54: 2393-2401. 10.1002/art.22023.CrossRefPubMed Ahmed S, Pakozdi A, Koch AE: Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2006, 54: 2393-2401. 10.1002/art.22023.CrossRefPubMed
25.
go back to reference Rabquer BJ, Pakozdi A, Michel JE, Gujar BS, Haines GK, Imhof BA, Koch AE: Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum. 2008, 58: 3020-3029. 10.1002/art.23867.CrossRefPubMedPubMedCentral Rabquer BJ, Pakozdi A, Michel JE, Gujar BS, Haines GK, Imhof BA, Koch AE: Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum. 2008, 58: 3020-3029. 10.1002/art.23867.CrossRefPubMedPubMedCentral
26.
go back to reference Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE: Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res. 2003, 93: 321-329. 10.1161/01.RES.0000087641.56024.DA.CrossRefPubMed Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE: Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res. 2003, 93: 321-329. 10.1161/01.RES.0000087641.56024.DA.CrossRefPubMed
27.
go back to reference Marotte H, Ruth JH, Campbell PL, Koch AE, Ahmed S: Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis. Rheumatology (Oxford). 2010, 49: 467-479. 10.1093/rheumatology/kep397.CrossRef Marotte H, Ruth JH, Campbell PL, Koch AE, Ahmed S: Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis. Rheumatology (Oxford). 2010, 49: 467-479. 10.1093/rheumatology/kep397.CrossRef
28.
go back to reference Ruth JH, Volin MV, Haines GK, Woodruff DC, Katschke KJ, Woods JM, Park CC, Morel JC, Koch AE: Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum. 2001, 44: 1568-1581. 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1.CrossRefPubMed Ruth JH, Volin MV, Haines GK, Woodruff DC, Katschke KJ, Woods JM, Park CC, Morel JC, Koch AE: Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum. 2001, 44: 1568-1581. 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1.CrossRefPubMed
29.
go back to reference Amin MA, Haas CS, Zhu K, Mansfield PJ, Kim MJ, Lackowski NP, Koch AE: Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood. 2006, 107: 2252-2261. 10.1182/blood-2005-05-2011.CrossRefPubMedPubMedCentral Amin MA, Haas CS, Zhu K, Mansfield PJ, Kim MJ, Lackowski NP, Koch AE: Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood. 2006, 107: 2252-2261. 10.1182/blood-2005-05-2011.CrossRefPubMedPubMedCentral
30.
go back to reference Mortier A, Gouwy M, Van Damme J, Proost P: Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp Cell Res. 2011, 317: 642-654. 10.1016/j.yexcr.2010.11.016.CrossRefPubMed Mortier A, Gouwy M, Van Damme J, Proost P: Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp Cell Res. 2011, 317: 642-654. 10.1016/j.yexcr.2010.11.016.CrossRefPubMed
31.
32.
go back to reference Nabeshima S, Chiba T, Takei Y, Ono A, Moriya K, Onozaki K: Development of glycosylated human interleukin-1alpha, neoglyco IL-1alpha, coupled with D-galactose monosaccharide: biological activities in vivo. Glycoconj J. 1998, 15: 491-498. 10.1023/A:1006987020372.CrossRefPubMed Nabeshima S, Chiba T, Takei Y, Ono A, Moriya K, Onozaki K: Development of glycosylated human interleukin-1alpha, neoglyco IL-1alpha, coupled with D-galactose monosaccharide: biological activities in vivo. Glycoconj J. 1998, 15: 491-498. 10.1023/A:1006987020372.CrossRefPubMed
33.
go back to reference Lauc G, Essafi A, Huffman JE, Hayward C, Knezevic A, Kattla JJ, Polasek O, Gornik O, Vitart V, Abrahams JL, Pučić M, Novokmet M, Redžić I, Campbell S, Wild SH, Borovečki F, Wang W, Kolčić I, Zgaga L, Gyllensten U, Wilson JF, Wright AF, Hastie ND, Campbell H, Rudd PM, Rudan I: Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation. PLoS Genet. 2010, 6: e1001256-10.1371/journal.pgen.1001256.CrossRefPubMedPubMedCentral Lauc G, Essafi A, Huffman JE, Hayward C, Knezevic A, Kattla JJ, Polasek O, Gornik O, Vitart V, Abrahams JL, Pučić M, Novokmet M, Redžić I, Campbell S, Wild SH, Borovečki F, Wang W, Kolčić I, Zgaga L, Gyllensten U, Wilson JF, Wright AF, Hastie ND, Campbell H, Rudd PM, Rudan I: Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation. PLoS Genet. 2010, 6: e1001256-10.1371/journal.pgen.1001256.CrossRefPubMedPubMedCentral
34.
go back to reference Ravn V, Dabelsteen E: Tissue distribution of histo-blood group antigens. APMIS. 2000, 108: 1-28. 10.1034/j.1600-0463.2000.d01-1.x.CrossRefPubMed Ravn V, Dabelsteen E: Tissue distribution of histo-blood group antigens. APMIS. 2000, 108: 1-28. 10.1034/j.1600-0463.2000.d01-1.x.CrossRefPubMed
35.
go back to reference Terahara K, Nochi T, Yoshida M, Takahashi Y, Goto Y, Hatai H, Kurokawa S, Jang MH, Kweon MN, Domino SE, Hiroi T, Yuki Y, Tsunetsugu-Yokota Y, Kobayashi K, Kiyono H: Distinct fucosylation of M cells and epithelial cells by Fut1 and Fut2, respectively, in response to intestinal environmental stress. Biochem Biophys Res Commun. 2011, 404: 822-828. 10.1016/j.bbrc.2010.12.067.CrossRefPubMed Terahara K, Nochi T, Yoshida M, Takahashi Y, Goto Y, Hatai H, Kurokawa S, Jang MH, Kweon MN, Domino SE, Hiroi T, Yuki Y, Tsunetsugu-Yokota Y, Kobayashi K, Kiyono H: Distinct fucosylation of M cells and epithelial cells by Fut1 and Fut2, respectively, in response to intestinal environmental stress. Biochem Biophys Res Commun. 2011, 404: 822-828. 10.1016/j.bbrc.2010.12.067.CrossRefPubMed
36.
go back to reference Szulman AE: Chemistry, distribution, and function of blood group substances. Annu Rev Med. 1966, 17: 307-322. 10.1146/annurev.me.17.020166.001515.CrossRefPubMed Szulman AE: Chemistry, distribution, and function of blood group substances. Annu Rev Med. 1966, 17: 307-322. 10.1146/annurev.me.17.020166.001515.CrossRefPubMed
37.
go back to reference Ma B, Simala-Grant JL, Taylor DE: Fucosylation in prokaryotes and eukaryotes. Glycobiology. 2006, 16: 158R-184R. 10.1093/glycob/cwl040.CrossRefPubMed Ma B, Simala-Grant JL, Taylor DE: Fucosylation in prokaryotes and eukaryotes. Glycobiology. 2006, 16: 158R-184R. 10.1093/glycob/cwl040.CrossRefPubMed
38.
go back to reference Zhu K, Amin MA, Zha Y, Harlow LA, Koch AE: Mechanism by which H-2 g, a glucose analog of blood group H antigen, mediates angiogenesis. Blood. 2005, 105: 2343-2349. 10.1182/blood-2004-08-3140.CrossRefPubMed Zhu K, Amin MA, Zha Y, Harlow LA, Koch AE: Mechanism by which H-2 g, a glucose analog of blood group H antigen, mediates angiogenesis. Blood. 2005, 105: 2343-2349. 10.1182/blood-2004-08-3140.CrossRefPubMed
39.
go back to reference Amin MA, Ruth JH, Haas CS, Pakozdi A, Mansfield PJ, Haghshenas J, Koch AE: H-2 g, a glucose analog of blood group H antigen, mediates mononuclear cell recruitment via Src and phosphatidylinositol 3-kinase pathways. Arthritis Rheum. 2008, 58: 689-695. 10.1002/art.23296.CrossRefPubMed Amin MA, Ruth JH, Haas CS, Pakozdi A, Mansfield PJ, Haghshenas J, Koch AE: H-2 g, a glucose analog of blood group H antigen, mediates mononuclear cell recruitment via Src and phosphatidylinositol 3-kinase pathways. Arthritis Rheum. 2008, 58: 689-695. 10.1002/art.23296.CrossRefPubMed
40.
go back to reference Przybysz M, Maszczak D, Borysewicz K, Szechinski J, Katnik-Prastowska I: Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis. Glycoconj J. 2007, 24: 543-550. 10.1007/s10719-007-9049-9.CrossRefPubMed Przybysz M, Maszczak D, Borysewicz K, Szechinski J, Katnik-Prastowska I: Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis. Glycoconj J. 2007, 24: 543-550. 10.1007/s10719-007-9049-9.CrossRefPubMed
41.
go back to reference Kratz EM, Borysewicz K, Katnik-Prastowska I: Terminal monosaccharide screening of synovial immunoglobulins G and A for the early detection of rheumatoid arthritis. Rheumatol Int. 2010, 30: 1285-1292. 10.1007/s00296-009-1139-5.CrossRefPubMed Kratz EM, Borysewicz K, Katnik-Prastowska I: Terminal monosaccharide screening of synovial immunoglobulins G and A for the early detection of rheumatoid arthritis. Rheumatol Int. 2010, 30: 1285-1292. 10.1007/s00296-009-1139-5.CrossRefPubMed
42.
go back to reference Paleolog EM, Hunt M, Elliott MJ, Feldmann M, Maini RN, Woody JN: Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis. Arthritis Rheum. 1996, 39: 1082-1091. 10.1002/art.1780390703.CrossRefPubMed Paleolog EM, Hunt M, Elliott MJ, Feldmann M, Maini RN, Woody JN: Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis. Arthritis Rheum. 1996, 39: 1082-1091. 10.1002/art.1780390703.CrossRefPubMed
43.
go back to reference Mathieu S, Gerolami R, Luis J, Carmona S, Kol O, Crescence L, Garcia S, Borentain P, El-Battari A: Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth. Int J Cancer. 2007, 121: 1680-1689. 10.1002/ijc.22797.CrossRefPubMed Mathieu S, Gerolami R, Luis J, Carmona S, Kol O, Crescence L, Garcia S, Borentain P, El-Battari A: Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth. Int J Cancer. 2007, 121: 1680-1689. 10.1002/ijc.22797.CrossRefPubMed
44.
go back to reference Szekanecz Z, Szegedi G, Koch AE: Cellular adhesion molecules in rheumatoid arthritis: regulation by cytokines and possible clinical importance. J Investig Med. 1996, 44: 124-135.PubMed Szekanecz Z, Szegedi G, Koch AE: Cellular adhesion molecules in rheumatoid arthritis: regulation by cytokines and possible clinical importance. J Investig Med. 1996, 44: 124-135.PubMed
45.
go back to reference Palumberi D, Aldi S, Ermini L, Ziche M, Finetti F, Donnini S, Rosati F: RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation. J Cell Biochem. 2010, 111: 229-238. 10.1002/jcb.22692.CrossRefPubMed Palumberi D, Aldi S, Ermini L, Ziche M, Finetti F, Donnini S, Rosati F: RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation. J Cell Biochem. 2010, 111: 229-238. 10.1002/jcb.22692.CrossRefPubMed
46.
go back to reference Kwiatkowski P, Artrip JH, Edwards NM, Lietz K, Tugulea S, Michler RE, McKenzie IF, Sandrin MS, Itescu S: High-level porcine endothelial cell expression of alpha(1,2)-fucosyltransferase reduces human monocyte adhesion and activation. Transplantation. 1999, 67: 219-226. 10.1097/00007890-199901270-00006. discussion 193–214CrossRefPubMed Kwiatkowski P, Artrip JH, Edwards NM, Lietz K, Tugulea S, Michler RE, McKenzie IF, Sandrin MS, Itescu S: High-level porcine endothelial cell expression of alpha(1,2)-fucosyltransferase reduces human monocyte adhesion and activation. Transplantation. 1999, 67: 219-226. 10.1097/00007890-199901270-00006. discussion 193–214CrossRefPubMed
47.
go back to reference Tolboom TC, van der Helm-Van Mil AH, Nelissen RG, Breedveld FC, Toes RE, Huizinga TW: Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum. 2005, 52: 1999-2002. 10.1002/art.21118.CrossRefPubMed Tolboom TC, van der Helm-Van Mil AH, Nelissen RG, Breedveld FC, Toes RE, Huizinga TW: Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum. 2005, 52: 1999-2002. 10.1002/art.21118.CrossRefPubMed
Metadata
Title
Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation
Authors
Takeo Isozaki
Jeffrey H Ruth
Mohammad A Amin
Phillip L Campbell
Pei-Suen Tsou
Christine M Ha
G Kenneth Haines III
Gautam Edhayan
Alisa E Koch
Publication date
01-02-2014
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2014
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4456

Other articles of this Issue 1/2014

Arthritis Research & Therapy 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.